tiprankstipranks
Trending News
More News >
Calyx Bio-Ventures Inc (TSE:CYX.H)
:CYX.H
Canadian Market

Calyx Bio-Ventures (CYX.H) Financial Statements

Compare
7 Followers

Calyx Bio-Ventures Financial Overview

Calyx Bio-Ventures's market cap is currently C$947.82K. The company's EPS TTM is C$; its P/E ratio is ―; Calyx Bio-Ventures is scheduled to report earnings on ―, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 18Dec 17Dec 16Dec 15Dec 14
Income Statement
Total Revenue
Gross Profit$ 2.40K$ 54.05K$ 61.14K$ 33.05K-
Operating Income$ -796.00K$ -1.06M$ -694.83K$ -450.99K$ -568.28K
EBITDA$ -1.62M$ -918.45K$ -556.69K$ -39.17K$ -513.60K
Net Income$ -2.49M$ -1.45M$ -696.34K$ -151.85K$ -526.99K
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 666.20K$ 2.33M$ 877.37K$ 334.54K$ 336.68K
Total Debt$ 0.00$ 52.00K$ 141.30K$ 0.00$ 0.00
Net Debt$ -726.00$ -375.72K$ -47.35K$ -7.58K$ -17.08K
Total Liabilities$ 801.39K$ 710.78K$ 191.43K$ 45.60K$ 81.92K
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -593.53K$ -863.74K$ -220.36K$ -300.24K$ -480.46K
Operating Cash Flow$ -593.53K$ -863.74K$ -220.36K$ -300.24K$ -480.46K
Investing Cash Flow
Financing Cash Flow
Currency in USD

Calyx Bio-Ventures Earnings and Revenue History

Calyx Bio-Ventures Debt to Assets

Calyx Bio-Ventures Cash Flow

Calyx Bio-Ventures Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.